Global Corneal Transplant Market
The global corneal transplant market is expected to reach USD 698.94 million by 2031 from USD 436.38 million in 2023, growing at a CAGR of 6.1% in the forecast period of 2024 to 2031.
Global Corneal Transplant Market, By Procedure Type (Endothelial Keratoplasty, Penetrating Keratoplasty, Anterior Lamellar Keratoplasty (ALK), Corneal Limbal Stem Cell Transplant, Artifical Cornea Transplant, and Others), Type (Human Cornea and Synthetic), Donor Type (Autograft and Allograft), Graft Type (Partial Thickness Grafts (Lamellar) and Full Thickness Grafts (Penetrating)), Surgery Type (Conventional Surgery, Laser-Assisted Surgery), Indication (Fuch's Endothelial Dystrophy, Infectious Keratitis, Bullous Keratopathy, Keratoconus, Regraft Procedures, Corneal Scarring, Corneal Ulcers, and Others), Gender (Female and Male), Age Group (Geriatric, Adult, and Pediatric), End User (Hospitals, Eye Clinics, Ambulatory Surgical Centers, Academic & Research Institutes, and Others), Countries (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Netherlands, Switzerland, Turkey, Belgium, Denmark, Norway, Sweden, Poland, Rest of Europe, Brazil, Argentina, Rest of South America, China, India, Japan, Australia, South Korea, Singapore, Philippines, Malaysia, Indonesia, Thailand and Rest of Asia-Pacific, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa) - Industry Trends and Forecast to 2031
Overview of Global Corneal Transplant Market Dynamics:Driver
• Increasing prevalence of eye diseases
Restrain
• High cost associated with corneal transplant surgery
Opportunity
• Rise in healthcare infrastructure
Market Players:
The key market players operating in the global corneal transplant market are listed below:
• ZEISS Group (Carl Zeiss Meditec AG.)
• Alcon
• CorneaGen
• Ziemer Ophthalmic Systems AG
• RUMEX International Co.